Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value
Aim: Use long-term follow-up data from the IMPERIAL study to determine whether drug-eluting polymer based nitinol stent treatment can delay the time to repeat intervention for femoropopliteal artery disease and how such a delay may result in cost savings in a value-based episode of care. Patients &a...
Saved in:
Main Authors: | Yoshimitsu Soga (Author), Masahiko Fujihara (Author), Osamu Iida (Author), Anvar Babaev (Author), Daizo Kawasaki (Author), Thomas Zeller (Author), David O'Connor (Author), Anna M Chavez (Author), Stefan Muller-Hulsbeck (Author), Michael R Jaff (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tips and tricks in femoropopliteal lesions
by: Hüsnü Değirmenci, et al.
Published: (2021) -
Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023) -
Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
by: Spadaccio Cristiano, et al.
Published: (2016) -
Angioplasty and drug-eluting stent for vertebral artery stenosis
by: Nabil A Metwally, et al.
Published: (2018) -
Optimized sirolimus-eluting stent by coating asymmetrically with biodegradable and cytocompatible polymers
by: Seong Min Kim, et al.
Published: (2016)